Image Place holder

Omar A. Castaneda Puglianini, MD


Specialty: Medical Oncology
Program: Blood and Marrow Transplant and Cellular Immunotherapy

Call 1-888-MOFFITT
(1-888-663-3488)

or call 1-888-MOFFITT
(1-888-663-3488)

Overview

Dr. Castaneda Puglianini’s clinical and research interests include autologous and allogeneic hematopoietic stem cell transplantation and immunotherapy for plasma cell malignancies.

Education & Training

Board Certification:

  • Internal Medicine
  • Internal Medicine

Fellowship:

  • Virginia Commonwealth University Massey Cancer Center - Hematology and Oncology
  • H. Lee Moffitt Cancer Center and Research Institute - Blood and Marrow Transplantation

Residency:

  • Albert Einstein College of Medicine Jacobi Medical Center - Internal Medicine

Medical School:

  • Universidad Peruana Cayetano Heredia Alberto Hurtado School of Medicine - MD
Participating Trials

CLINICAL TRIAL 18346
Evaluating the Safety and Biological Activity of a Dendritic Cell Survivin Vaccine in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplantation
Condition: Malignant Hematology
Intervention: G-CSF; Prevnar13; Survivin-Dendritic Cell Vaccine
Open

CLINICAL TRIAL 19230
Phase 2, Randomized, Open-Label Study Comparing Daratumumab, Lenalidomide, Bortezomib,and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma Eligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation
Condition: Malignant Hematology
Intervention: Bortezomib; CC-5013 (Lenalidomide); Daratumumab; Dexamethasone; Lenalidomide (Revlimid); PS-341 (Bortezomib); Velcade (Bortezomib)
Open

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).

Publications

  • Casas J, Castañeda O, Prezza P, Castillo M, Llosa L. [An unusual presentation of liver involvement in hereditary hemorrhagic telangiectasia biliary disease]. Rev Gastroenterol Peru. 2009 Jul;29(3):266-271. Pubmedid: 19898600.